Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Articles

Review

Epigenetic and Epitranscriptomic Regulation of Immune Checkpoint Response in Hepatocellular Carcinoma: Mechanisms, Therapeutic Targeting, and Translational Challenges

Yafei Zhi1,2,3,4,5, Yan Guo2,3,4, Huifang Wei2,3,5, Michael P. Gantier6, Xiwen Ma7, Zigang Dong2,4,5, Kangdong Liu2,3,4,5
Published online: October 7, 2026
1Cell Research and Translational Center, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450007, China
2State Key Laboratory of Metabolic dysregulation & the Prevention and Treatment of Esophageal Cancer; School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450000, Henan, China
3Tianjian Laboratory of Advanced Biomedical Sciences; Zhengzhou Central Hospital, Zhengzhou University, Zhengzhou 450000, Henan, China
4China-US (Henan) Hormel Cancer Institute; Zhengzhou 450000, Henan, China
5Cancer Chemoprevention International Collaboration Laboratory; Zhengzhou 450000, Henan, China
6Research Group Head, Nucleic Acids and Innate Immunity, Centre for Innate Immunity and Infectious Disease, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia
7Metabolic Disease Research Center, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450052, Henan, China
Corresponding author:  Xiwen Ma, Tel: 0371 67690000, 
Email: maxiwen@zzu.edu.cn
Zigang Dong, Tel: 86-371-6778-3018, Fax: 86-371-6778-3018, 
Email: dongzg@zzu.edu.cn
Kangdong Liu, Tel: 67781885, Fax: 86-371-6558-7227, 
Email: kdliu@zzu.edu.cn
Received: 16 June 2026   • Revised: 10 September 2026   • Accepted: 24 September 2026
  • 944 Views
  • 56 Download
  • 0 Crossref
  • 0 Scopus

Immune checkpoint inhibitors (ICIs) have reshaped systemic therapy for hepatocellular carcinoma (HCC), but durable benefit remains limited to a subset of patients because of tumor-intrinsic and microenvironmental mechanisms of immune resistance. Canonical epigenetic and epitranscriptomic alterations, including DNA methylation, histone modifications and chromatin remodeling, and epitranscriptomic RNA modifications, can influence tumor immune visibility by regulating antigen presentation, interferon responses, chemokine production, T-cell recruitment and function, and immunosuppressive programs in myeloid and stromal cells. This review critically evaluates HCC-specific evidence linking these regulatory mechanisms to immune checkpoint responsiveness. Emphasis is placed on crosstalk among DNA methylation, histone/chromatin regulation, and N6-methyladenosine (m6A)-dependent pathways; transcriptional–epigenetic stabilization of T-cell dysfunction; and epigenetic or epitranscriptomic remodeling of myeloid and stromal compartments, including cancer-associated fibroblasts. We further evaluate candidate therapeutic targets using a tiered evidence framework that integrates molecular association, mechanistic validation, pharmacologic validation, evidence from ICI-combination studies, and clinical validation. We assess therapeutic targets by evidence maturity and discuss emerging combination strategies and HCC-specific translational challenges, including chronic liver disease, limited hepatic reserve, and biomarker-guided patient selection. Although preclinical studies support several candidate mechanisms for modulating ICI responsiveness, mature clinical evidence for epigenetic–ICI combinations in HCC remains limited. These strategies should therefore be regarded as mechanistically compelling but clinically unproven and require rigorously designed, biomarker-integrated HCC trials with pharmacodynamic confirmation of immune reprogramming and careful safety evaluation.

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

Epigenetic and Epitranscriptomic Regulation of Immune Checkpoint Response in Hepatocellular Carcinoma: Mechanisms, Therapeutic Targeting, and Translational Challenges
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:
Include:
Epigenetic and Epitranscriptomic Regulation of Immune Checkpoint Response in Hepatocellular Carcinoma: Mechanisms, Therapeutic Targeting, and Translational Challenges
Close